Cite
HARVARD Citation
Paszkiewicz‐Kozik, E. et al. (n.d.). OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8). Hematological oncology. pp. 436-437. [Online].